Review Articles
71. Recognition and management of neuropsychiatric complications in Parkinson's disease.
- Author
- Ferreri F; Agbokou C; Gauthier S;
- Institution
- Alzheimer's Disease Research Unit, McGill Centre for Studies in Aging, Douglas Hospital, Verdun, Quebec, Canada.
- Journal
- CMAJ. 2006 Dec 5;175(12):1545-52.
- Abstract URL
- Click here to view abstract
72. Criteria for deep-brain stimulation in Parkinson's disease: review and analysis.
- Author
- Moro E; Lang AE;
- Institution
- University of Toronto, Department of Medicine, Movement Disorders Center, 399 Bathurst Street, McL7 402, Canada. elena.moro@uhn.on.ca
- Journal
- Expert Rev Neurother. 2006 Nov;6(11):1695-705.
- Abstract URL
- Click here to view abstract
73. Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesias.
- Author
- Hauser RA;
- Institution
- Parkinson's Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, University of South Florida, Tampa, FL, USA.
- Journal
- Geriatrics. 2006 Sep;61(9):14-20.
- Abstract URL
- Click here to view abstract
74. Neuroprotective therapy in Parkinson disease.
- Author
- Chen S; Le W;
- Institution
- Institute of Neurology, Ruijin Hospital, Shanghai 2nd Medical University, Shanghai, China.
- Journal
- Am J Ther. 2006 Sep-Oct;13(5):445-57.
- Abstract URL
- Click here to view abstract
75. Emerging drugs for Parkinson's disease.
- Author
- Morgan JC; Sethi KD; Morgan JC; Sethi KD;
- Institution
- Medical College of Georgia, Movement Disorders Program, Department of Neurology, 1429 Harper Street, HF-1121, Augusta, GA 30912, USA. jmorgan@mcg.edu
- Journal
- Expert Opin Emerg Drugs. 2006 Sep;11(3):403-17.
- Abstract URL
- Click here to view abstract
76. Excessive daytime sleepiness and unintended sleep in Parkinson's disease.
- Author
- Rye DB;
- Institution
- Department of Neurology, Emory University School of Medicine, 101 Woodruff Circle, WMRB-Suite 6000, PO Drawer V, Atlanta, GA 30322, USA. drye@emory.edu
- Journal
- Curr Neurol Neurosci Rep. 2006 Mar;6(2):169-76.
- Abstract URL
- Click here to view abstract
77. Rotigotine: a novel dopamine agonist for the transdermal treatment of Parkinson's disease.
- Author
- Zareba G;
- Institution
- Department of Environmental Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York 14642, USA. grazyna_zareba@urmc.rochester.edu
- Journal
- Drugs Today (Barc). 2006 Jan;42(1):21-8.
- Abstract URL
- Click here to view abstract
78. Non-motor symptoms of Parkinson's disease: diagnosis and management.
- Author
- Chaudhuri KR; Healy DG; Schapira AH;
- Institution
- Movement Disorders Unit, Kings College Hospital, Guy's King's and St Thomas' School of Medicine, London, UK. ray.chaudhuri@uhl.nhs.uk
- Journal
- Lancet Neurol. 2006 Mar;5(3):235-45.
- Abstract URL
- Click here to view abstract
79. Neural stimulation for Parkinson's disease: current therapies and future directions.
- Author
- Neimat JS; Hamani C; Lozano AM;
- Institution
- Toronto Western Hospital, Toronto, Ontario M5T 2S8, Canada. jneimat@gmail.com
- Journal
- Expert Rev Neurother. 2006 Jan;6(1):101-9.
- Abstract URL
- Click here to view abstract
80. Parkinson's disease management strategies.
- Author
- Rajput A; Rajput AH;
- Institution
- Royal University Hospital, Saskatchewan, S7N 0W8, Canada. rajputa@sask.usask.ca
- Journal
- Expert Rev Neurother. 2006 Jan;6(1):91-9.
- Abstract URL
- Click here to view abstract
Previous Section
